# Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

> clinical trial · VERIFIED · 2026-07-29

Status: NOT_YET_RECRUITING · Sponsor: The Affiliated People's Hospital of Ningbo University · Condition: Multiple Myeloma

- Company: The Affiliated People's Hospital of Ningbo University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07732712

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
